(PFE) - Analyzing Pfizer's Short Interest
Pfizer and Schlumberger Are January Bounce Candidates
Morgan Stanley Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $31
Morgan Stanley Sticks to Their Hold Rating for Pfizer (PFE)
S&P 500, Dow Hit Records Right After Open | Live Stock
FDA Approves BridgeBio Pharma's Drug For Rare Heart Disease, Poised To Challenge Pfizer In Lucrative Yet Competitive Market
Hong Kong stocks fluctuate | Zai Lab (09688) rises over 5% as it cooperates with Pfizer on the new antibacterial drug in mainland China.
zai lab (09688) rose more than 5%, as of the deadline, it increased by 5.26%, closing at 20.8 Hong Kong dollars, with a turnover of 7.8692 million Hong Kong dollars.
Laurel Lee From Florida's 15th District Makes Notable Trades in Apple, GE Vernova, and Pfizer
Pfizer Meets Amyloidosis Rival as BridgeBio Wins FDA Nod for Attruby
These 4 Measures Indicate That Pfizer (NYSE:PFE) Is Using Debt Extensively
Trump Nominates Marty Makary For FDA Commissioner
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
Pfizer Options Spot-On: On November 22nd, 411.31K Contracts Were Traded, With 3.36 Million Open Interest
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day
FDA Accepts Bayer's Application for Label Expansion of Nubeqa
Novartis Raises Sales Outlook for Mid-Term, Acquires Kate Therapeutics
Pfizer Inc. (PFE) Jefferies London Healthcare Conference (Transcript)
Market Climbs, Bitcoin Close to $100k | Live Stock
Pfizer Stock Drops 10% In November On News Of Kennedy's HHS Nomination
Pfizer Options Spot-On: On November 21st, 265.78K Contracts Were Traded, With 3.35 Million Open Interest